Geunyoung Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Geunyoung Cho has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hayyoung Lee
Postech Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea
23 shared publications - Hye Jin Jeong
Institute of Membrane Proteins, POSTECH, Pohang, Republic of South Korea
23 shared publications - Hyun-Jung An
Gyeongbuk Institute for Bio Industry, Andong-si, Gyeongbuk, Republic of South Korea
23 shared publications - Jie-Oh Lee
Department of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology, 77 Cheongam-ro, Nam-gu, Pohang-si 37673, Republic of Korea
23 shared publications - Sang Min Park
Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea
23 shared publications - Van Anh Do-Thi
Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea
23 shared publications
Latest Publications
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Clodronate-encapsulated liposomes show cytotoxicity to BMDMs but not to B16F10 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Clodronate-encapsulated liposomes show cytotoxicity to BMDMs but not to B16F10 cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Gating strategy to analyze the chemotactic migration of immune cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Gating strategy to analyze the chemotactic migration of immune cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
IL-9 promotes M1 polarization of macrophages in vitro
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
IL-9 promotes M1 polarization of macrophages in vitro
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Clodronate-encapsulated liposomes show cytotoxicity to BMDMs but not to B16F10 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Clodronate-encapsulated liposomes show cytotoxicity to BMDMs but not to B16F10 cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Bodyweight change of the tumor-implanted mice in Figure 6
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Bodyweight change of the tumor-implanted mice in Figure 6
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Treatment with IL-9 induces STAT1 and STAT3 phosphorylation in RAW 264.7 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Treatment with IL-9 induces STAT1 and STAT3 phosphorylation in RAW 264.7 cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Expression of IL-9R on the surface of B16F10 and 4T1 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Expression of IL-9R on the surface of B16F10 and 4T1 cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Expression of IL-9R on the surface of B16F10 and 4T1 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Expression of IL-9R on the surface of B16F10 and 4T1 cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Data from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Tumor-associated macrophages (TAM) are involved in tumor progression, metastasis, and immunosuppression. Because TAMs are highly plastic and could alter their phenotypes to proinflammatory M1 in response to environmental stimuli, reeducating TAMs has emerged as a promising approach to overcoming the challenges of solid cancer treatment. This study investigated the effect of IL9 on macrophage M1 polarization and verified its antitumor potential to retrain TAMs and promote chemokine secretion. We demonstrated that IL9 stimulated macrophage proliferation and polarized them toward the proinflammatory M1 phenotype in an IFNγ-dependent manner. Tumor-localized IL9 also polarized TAMs toward M1 in vivo and made them release CCL3/4 and CXCL9/10 to recruit antitumor immune cells, including T and natural killer cells, into the tumor microenvironment. Furthermore, peritoneal treatment with recombinant IL9 delayed the growth of macrophage-enriched B16F10 melanoma and 4T1 breast cancer in syngeneic mice, although IL9 treatment did not reduce tumor growth in the absence of macrophage enrichment. These results demonstrate the efficacy of IL9 in macrophage polarization to trigger antitumor immunity.Significance:These findings clarified the effect of IL9 on macrophage M1 polarization and verified its antitumor potential through retraining TAMs and chemokine secretion.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Tumor-associated macrophages (TAM) are involved in tumor progression, metastasis, and immunosuppression. Because TAMs are highly plastic and could alter their phenotypes to proinflammatory M1 in response to environmental stimuli, reeducating TAMs has emerged as a promising approach to overcoming the challenges of solid cancer treatment. This study investigated the effect of IL9 on macrophage M1 polarization and verified its antitumor potential to retrain TAMs and promote chemokine secretion. We demonstrated that IL9 stimulated macrophage proliferation and polarized them toward the proinflammatory M1 phenotype in an IFNγ-dependent manner. Tumor-localized IL9 also polarized TAMs toward M1 in vivo and made them release CCL3/4 and CXCL9/10 to recruit antitumor immune cells, including T and natural killer cells, into the tumor microenvironment. Furthermore, peritoneal treatment with recombinant IL9 delayed the growth of macrophage-enriched B16F10 melanoma and 4T1 breast cancer in syngeneic mice, although IL9 treatment did not reduce tumor growth in the absence of macrophage enrichment. These results demonstrate the efficacy of IL9 in macrophage polarization to trigger antitumor immunity.Significance:These findings clarified the effect of IL9 on macrophage M1 polarization and verified its antitumor potential through retraining TAMs and chemokine secretion.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Treatment with IL-9 induces STAT1 and STAT3 phosphorylation in RAW 264.7 cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Treatment with IL-9 induces STAT1 and STAT3 phosphorylation in RAW 264.7 cells